Effects of UC-II, Glucosamine and Curcumin Supplementation on Knee Pain and Inflammation.
CompletedNot applicableNCT06581094
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This research evaluated the effects of UCII, glucosamine and curcumin supplementation on knee pain and inflammation.
Study details
- Official title
- Effects of UC-II, Glucosamine and Curcumin Supplementation on Knee Pain and Inflammation: A Randomized, Single-blind, Placebo-controlled Parallel-group Trial
- Conditions
- Interventions
- Dietary supplement: UCII, glucosamine and curcumin
- Dietary supplement: Placebo
- Sponsor
- Taipei Medical University
- Start date
- 2024-08-20
- Primary completion
- 2024-11-14
- Sex
- All
- Age range
- from 20 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Taiwan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Knee plain Exclusion Criteria: * Severe diseases of the heart, liver, kidneys, endocrine system, and other organs * Long-term use of medication * Infection, hypertension, diabetes, cerebrovascular disease, heart disease, liver disease, kidney disease, gastrointestinal disease * Allergy to this product
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06581094